ArticleAesthetic plastic surgery2026
MRI Manifestations of Facial Paralysis Following Retroauricular Hyaluronic Acid Injection.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundRetroauricular hyaluronic acid (HA) injection can enhance the cranio-auricular angle, thereby reducing perceived facial width and enhancing aesthetic appeal. Although this is generally a safe procedure, acute facial nerve paralysis is a rare but devastating complication.
objectiveThe aim of this study is to characterize the MRI features of acute facial paralysis following retroauricular HA injection, including manifestations of nerve injury and the distribution of the injected material, and to infer the potential etiology of the facial paralysis based on imaging findings.
methods15 patients presenting with acute complete unilateral facial paralysis following retroauricular HA filler injection between December 1, 2023, and August 10, 2025 were identified. No perceivable improvement was seen despite non-surgical interventions for 2 weeks. MRI using a 3.0-T scanner was conducted to acquire gadolinium-enhanced T1-weighted and T2-weighted images. Each segment of the facial nerve was evaluated, and the diffusion range of the HA injection was observed by examining the contralateral side.
resultsMRI demonstrated significant enhancement of the facial nerve on the affected side compared to the unaffected side in the tympanic (P = 0.006), mastoid (P = 0.004), and parotid segments (P < 0.001) on contrast-enhanced T1-weighted images. Additionally, the HA filler exhibited extensive diffusion (46.7 ± 12.2 mm horizontally, 53.1 ± 12.2 mm vertically) and infiltrating adjacent tissue spaces.
conclusionsThis group of patients showed widespread distribution of HA beyond the injection site. Additionally, persistent facial nerve edema and enhancement were mainly localized to the tympanic segment and its distal end of the facial nerve, indicating a possible need for facial nerve decompression in this cohort. LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
41807623What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.